Blockchain Registration Transaction Record
Lantern Pharma Raises $4.4M to Fuel AI-Driven Oncology Pipeline
Lantern Pharma (LTRN) raises $4.4M in direct offering to advance AI-driven oncology pipeline including LP-184, LP-284, and withZeta.ai platform. Read more.
This capital injection enables Lantern Pharma to advance its AI-powered precision oncology pipeline, including clinical trials for LP-184, LP-284, and LP-300, and to commercialize its withZeta.ai platform. For patients and the medical community, this could mean faster development of targeted cancer therapies with fewer side effects. For investors, it signals confidence in Lantern's AI-driven approach to drug discovery, which has the potential to disrupt traditional oncology R&D and create long-term value.
| Blockchain | Details |
|---|---|
| Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
| Transaction ID | 0xd2deda8f2d69308487774375ac13710af4fd3690879b20063ace90584b649b2f |
| Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
| Chain | polygon-main |
| NewsRamp Digital Fingerprint | pendJtdi-2b5ddcf2fe310096f2a54419fc732b23 |